-
Master Plant Extracts deeply cultivates the advantages of B2B e-commerce and helps the industry to develop rapidly
Time of Update: 2021-07-22
Facilitate the digital marketing transformation of upstream companies With the rapid development of the Industrial Internet, its core value lies in improving the work efficiency of enterprises and the integration and full utilization of resources.
-
2021 National Two Sessions: The per capita financial subsidy standard for resident medical insurance will be increased by 30 yuan
Time of Update: 2021-07-21
At the Fourth Session of the 13th National People's Congress held on the morning of March 5, Premier Li Keqiang made a government work report . The report pointed out that the per capita financial
-
National essential medicine information flows out, and the catalogue adjustment may change the wind direction
Time of Update: 2021-07-21
(Brief comment: According to the speech, a total of 12 provinces have completed the comprehensive implementation plan of the basic medicine system and issued it .
-
The government work report is released. The key work direction in the field of medicine in 2021 is set!
Time of Update: 2021-07-21
Medicine: Strive to include more chronic diseases, common disease drugs and high-value medical consumables into centralized procurement and other methods to further reduce the burden of patients' medicines; promote vaccine development and free inoculation in an orderly manner, and improve scientific and precise prevention and control capabilities and levels; adhere to Emphasize both Chinese and Western medicine, and implement major projects for the revitalization and development of Chinese medicine .
-
The Food and Drug Administration issued the latest new regulations to ensure the traceability of the whole process of the new crown vaccine
Time of Update: 2021-07-21
The holders, disease prevention and control institutions, and the relevant parties of the vaccination unit shall truthfully record vaccine sales, storage (whether the code is scanned every time the transfer is made), transportation, and use information in accordance with the requirements of the national vaccine full-process electronic traceability system .
-
Several hot words to see the highlights of the two sessions in the first year of the "14th Five-Year Plan"
Time of Update: 2021-07-21
. Li Xiuxiang, representative of the National People's Congress and director of the Trade and Environment Research Center of Jiangxi University of Finance and Economics, said that during the "14th Five-Year Plan" period, it is necessary to improve the level of technological innovation and continuously achieve "from 0 to 1" breakthroughs in order to create new development momentum .
-
This year’s government work report on health work mainly mentioned these points
Time of Update: 2021-07-21
2. Deepen the comprehensive reform of public hospitals, expand pilot projects for the construction of national medical centers and regional medical centers, strengthen the construction of general practitioners and rural doctors, improve county-level medical service capabilities, and accelerate the construction of a hierarchical diagnosis and treatment system .
-
Zhong Suansui aspires to be the richest man in Asia!
Time of Update: 2021-07-21
The founder of Nongfu Spring, Zhong Sui Sui, became the richest man in China for the first time with a fortune of 550 billion yuan (RMB).
Zhong Suansui also founded another listed company, the vaccine manufacturer Wantai Bio, with a current market value of more than 10 billion U.
-
Difficulty analysis of live MAH on-site inspection and precautions for welcome inspection
Time of Update: 2021-07-20
Li Hongye, a GMP training lecturer from the provincial and local bureaus, shared the "Analysis of Difficulties in MAH On-site Inspection and Precautions for Preparatory Inspection" live broadcast on the afternoon of March 11 , focusing on solving the key difficulties of the company's MAH on-site inspection and the requirements for on-site inspection And case analysis .
-
The fifth batch of countries have arrows on the string, can Chinese medicine take care of itself?
Time of Update: 2021-07-20
At present, Qinghai Province, Jinhua, Zhejiang, Puyang, Henan, and other places are actively exploring centralized procurement for some varieties of Chinese patent medicines that are in high demand and high in value, and have achieved significant price reduction effects, and the reform results have benefited more people .
-
Solving the Dilemma of "One Pill": Viewing the Two Sessions from the Reform of "Three-medicine Interaction"
Time of Update: 2021-07-20
Figure 2 Analysis of the direction and current situation of the three-medicine linkage reform The medical end is mainly to reduce irrational use of drugs, irrational drug prices, standardize hospital behavior, and ultimately pave the way for freeing up space, adjusting structure, and ensuring connectivity .
-
The country is about to start special insulin procurement! The second batch of drug procurement in six provinces and two districts will begin soon!
Time of Update: 2021-07-20
According to the news received late at night last night, Nanjing’s main topics are four: • The country will carry out special procurement with quantity, and the first batch of test water varieties will be insulin .
-
Medical experts watch the two sessions!
Time of Update: 2021-07-19
To this end, Yaozhi Interview specially created a special topic of "Focus on the Drugs of the Two Sessions", interviewing five industry experts, including R&D experts, entrepreneurs, and traditional Chinese medicine practitioners, in the field of medicine, making suggestions on the field of the two sessions, and sending a message on the development trend of the industry .
-
Medical cost control and drug research and development under centralized drug procurement
Time of Update: 2021-07-19
Centralized drug procurement refers to a procurement method in which multiple medical institutions purchase the required drugs in the form of bidding through a centralized drug procurement organizati
-
The State Food and Drug Administration issued the "Announcement on the Registration Items of the Master File of Medical Devices" on the 12th
Time of Update: 2021-07-19
The Approval Center will review the main documents together after the related medical device has filed the relevant application for registration .
-
Yiling Pharmaceutical won the "2020 Inheritance and Innovation Enterprise of Traditional Chinese Medicine"
Time of Update: 2021-07-18
Under the guidance of collateral disease theory, Yiling Pharmaceutical uses modern high-tech research and development and production of scientific and technological Chinese medicine to promote the industrialization of Chinese medicine.
-
CPhI Pharma Online Urgent Purchase Product List 2020.03.16
Time of Update: 2021-07-18
cn] There will be free online purchasing matching activities every week.
If your company can provide the following products, please call or email us as soon as possible-the corresponding "serial number" or "name" of the product in the list; we will provide you with detailed procurement requirements and customer contact information .
-
Yiling Pharmaceutical: Let the party flag fly high on the front line of guaranteeing supply
Time of Update: 2021-07-18
"After the outbreak, more than 60 party members in the production center took the lead in returning to work overnight, fulfilling the responsibilities and missions of party members with practical actions, and producing 4 million boxes of Lianhua Qingwen every day .
-
Well-known machinery company, began to deploy medical and aesthetic equipment globally
Time of Update: 2021-07-18
Huadong Medicine's layout in the field of medical aesthetics dates back to 2013, when the company won the exclusive agency rights of South Korea's LG company's Yiwan brand hyaluronic acid in China .
-
The State Food and Drug Administration issued the "Regulations on the Supervision and Administration of Medical Devices"
Time of Update: 2021-07-16
Article 20 The medical device registrant and recorder shall perform the following obligations: (1) Establish a quality management system suitable for the product and maintain effective operation; (2) Formulate post-market research and risk management and control plans and ensure their effective implementation; (3) Conduct monitoring and re-evaluation of adverse events in accordance with the law; (4) Establish and implement a product traceability and recall system; (5) Other obligations stipulated by the drug regulatory department of the State Council .
